Dengue Literature Review

Pang2017 - DHF Pathogenesis Review

5 min read

Pang2017 - DHF Pathogenesis Review

Full citation: Pang X, Zhang R, Cheng G. (2017). Progress towards understanding the pathogenesis of dengue hemorrhagic fever. Virologica Sinica, 32(1), 16–22. https://doi.org/10.1007/s12250-016-3855-9

Raw file: [[raw/Pang2017.pdf]]

Summary

This is a 7-page narrative review from Tsinghua University (Beijing, China) that synthesises DHF pathogenesis across five axes: (1) NS1 protein and anti-NS1 antibodies, (2) DENV genome variation and sfRNA, (3) antibody-dependent enhancement, and (4) cross-reactive T cell responses. The review is primarily a secondary synthesis of established literature published up to 2016; it contains no original data.

The paper’s organisational value lies in consolidating multiple mechanistic threads (NS1 direct effects, anti-NS1 autoimmunity, complement, ADE, OAS, genome virulence) into a single causal map (Figure 1). It confirms the sfRNA/TRIM25/RIG-I IFN suppression mechanism (Manokaran 2015) and the anti-prM ADE model (Dejnirattisai 2010) while adding two mechanistic details that are underrepresented in the broader literature: the C5b-C9 → NLRP3 inflammasome complement pathway (Suresh 2016) and IL-10-driven T cell apoptosis as a mechanism for impaired viral clearance in DHF (Mathew & Rothman 2008; Green 1999).

Relative to Bhatt2020 - Dengue Pathogenesis Review (a more recent and detailed review already in this wiki), the incremental value is narrow but specific.

Study Design

  • Type: Narrative review
  • Sample size: N/A (no original data)
  • Setting: Tsinghua University, Beijing, China; published 2017
  • Population: N/A

Key Findings

NS1 and anti-NS1 antibodies

  • sNS1 is present in patient sera during acute DENV infection and correlates with disease severity (Libraty 2002 cited)
  • sNS1 activates TLR4 on macrophages/PBMCs → cytokine release → endothelial disruption (Modhiran 2015 cited)
  • NS1 → complement → C5b-C9 → NLRP3: sNS1 independently activates fluid-phase complement factors; a close correlation exists between NS1 concentration and C5b-C9 complex formation; C5b-C9 stimulates NLRP3 inflammasome-mediated expression of inflammatory cytokines associated with DHF (Kurosu 2007, Suresh 2016 cited)
  • Anti-NS1 → GPI-anchored NS1 → tyrosine phosphorylation → enhanced replication: Anti-NS1 antibodies bind GPI-anchored NS1 on infected cell membranes, activating signal transduction pathways leading to protein tyrosine phosphorylation, which may enhance DENV replication in infected cells (Jacobs 2000 cited) — distinct from the NF-κB cytokine-induction pathway
  • Anti-NS1 antibodies activate NF-κB in endothelial cells → IL-6, IL-8, MCP-1 (Lin 2005 cited; consistent with Lin2006 in this wiki)
  • NS1 sequence homology with plasminogen and integrin → autoantibodies cross-react with endothelial and platelet cells → NO production, apoptosis, platelet lysis/aggregation inhibition (Falconar 1997, Sun 2007 cited; consistent with Lin2001/Lin2006 in this wiki)
  • NS1-MIF-autophagy-vascular leakage pathway (Chen 2016 cited; consistent with Bhatt2020 in this wiki)

DENV genome and sfRNA

  • DENV-2 Southeast Asian genotype replicates at higher titres and is more virulent than the American genotype in humans and mosquitoes (Rico-Hesse 1997/1998 cited)
  • sfRNA (0.3–0.5 kb; generated by exoribonuclease XRN1 stalling at 3’ UTR) accumulates in infected cells → suppresses type I IFN signalling (Manokaran 2015 cited; consistent with Bhatt2020/wiki) and alters host mRNA stability (Moon 2012, Schnettler 2012 cited)

ADE

  • Secondary infection DHF risk: 118–208 per 1000 vs. 11–12 per 1000 in primary infection; ≥10-fold higher risk (Guzman 2013 cited)
  • ADE directed toward anti-E and anti-prM antibodies; anti-prM highlighted since Dejnirattisai 2010 (consistent with wiki)
  • FcγR-mediated uptake of virion-antibody complexes → enhanced DENV replication; FcγR-mediated ADE also suppresses intracellular antiviral innate immune responses and enhances IL-10 production (consistent with wiki)
  • FcγR-mediated ADE triggers robust cytokine/chemokine release from mast cells and immune cells → endothelial dysfunction

T cells

  • Cross-reactive low-affinity memory T cells from primary infection expand preferentially in secondary infection; produce IFN-γ, IL-2, TNF-α (Bozza 2008, Malavige 2012 cited) but clear the new serotype inefficiently (OAS mechanism; consistent with Bhatt2020/wiki)
  • IL-10-driven T cell apoptosis: IL-10 concentrations are elevated in sera of patients with severe dengue; IL-10 directly induces T cell apoptosis in acute DENV infection; IL-10 blockade significantly reduces T cell apoptosis; reduced T cell numbers in DHF vs. DF (Green 1999; Mathew & Rothman 2008 cited) → T cell apoptosis reduces viral clearance → impaired antiviral response → severe disease

Methods Used

  • N/A (review article)

Entities Mentioned

DENV-1, DENV-2, DENV-3, DENV-4, NS1 Protein, E Protein, prM Protein, Aedes aegypti, Aedes albopictus, CYD-TDV

Concepts Addressed

Antibody-Dependent Enhancement, Dengue Pathophysiology, Cytokine Storm, T Cell Responses in Dengue, Type I Interferon Response in Dengue, Original Antigenic Sin, Secondary Dengue Infection, Cross-Reactive Antibodies, NS1 Molecular Mimicry in Dengue, Dengue Clinical Classification

Relevance & Notes

Relative to the existing wiki, Pang2017 adds three specific mechanistic details not previously documented:

  1. C5b-C9 → NLRP3 inflammasome in the NS1-complement pathway (Suresh 2016): Guzman2016 notes complement activation and NS1’s role in glycocalyx shedding, but the NLRP3 inflammasome link between C5b-C9 and downstream inflammatory cytokine production in DHF was absent.

  2. Anti-NS1 antibody → GPI-anchored NS1 → tyrosine phosphorylation → enhanced DENV replication (Jacobs 2000): The wiki documents anti-NS1 NF-κB/cytokine pathway (Lin2006) and direct sNS1 TLR4 activation, but not this distinct GPI-anchored NS1 signal transduction route to enhanced viral replication. This is a second mechanism by which anti-NS1 antibodies may paradoxically worsen infection rather than clear it.

  3. IL-10 → T cell apoptosis (Mathew & Rothman 2008): The wiki documents IL-10 in Th2 skewing, plasmablast expansion (Sungnak2025), and Treg-mediated immunosuppression (Bhatt2020), but not the specific apoptotic effect of IL-10 on T cells in dengue — providing a mechanistic explanation for the reduced T cell numbers documented in DHF patients (Green 1999) and linking elevated IL-10 directly to impaired cellular clearance.

The review largely confirms Bhatt2020’s coverage of sfRNA/TRIM25/RIG-I, OAS, MIF-autophagy, and anti-prM ADE. The 74/67 citation count suggests moderate field traction.

Questions Raised

  • Does IL-10 blockade in dengue reduce T cell apoptosis without worsening the antibody-mediated pathology (since IL-10 is also anti-inflammatory)? The double role of IL-10 — driving T cell apoptosis AND reducing excessive inflammation — complicates therapeutic targeting.
  • Does the GPI-anchored NS1 → tyrosine phosphorylation mechanism operate in primary infection (before anti-NS1 antibodies are produced at titre) or only in secondary infection with anamnestic anti-NS1 IgG responses?
  • The C5b-C9/NLRP3 link is cited from Suresh 2016 (a general complement biology paper, not dengue-specific). Is there direct evidence that dengue-activated C5b-C9 activates NLRP3 in dengue patient samples?

Graph View

Backlinks